Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf170 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Maria-Eleni Syleouni und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chronic Disease Epidemiology, Epidemiology Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Breast Neoplasms, Postmenopause, Blood Proteins, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS, NHLBI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Background
Plasma proteomic data can be used to discover breast cancer risk biomarkers beyond established risk factors. Discovery using a large-scale platform in a diverse population is needed.
Methods
We investigated 4712 plasma proteins and breast cancer risk among postmenopausal women in a prospective cohort analysis in the Atherosclerosis Risk in Communities study. Proteins were measured by SomaScan 5K Assay. Incident cases were ascertained primarily from state cancer registries. We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) using Cox regression adjusting for risk factors and applied the Benjamini-Hochberg method to control false discovery. We determined whether the statistically significant proteins were confirmed in a case-cohort study within the European Prospective Investigation into Cancer and Nutrition.
Results
After median follow-up of 23.3 years, 340 of 4403 women had an incident breast cancer. Two proteins were statistically significantly associated after P value adjustment: per doubling, the hazard ratio of breast cancer was 1.45 (95% CI = 1.23 to 1.70; P = 7.47*10−6, Padjusted = .0370) for protein LEG1 homolog and 2.52 (95% CI = 1.66 to 3.83; P = 1.50*10−5, Padjusted = 0.0371) for adenosine diphosphate (ADP)–dependent glucokinase. Results were consistent in a lagged analysis and among Black (28.1%) and White women. In the European Prospective Investigation into Cancer and Nutrition, both associations were confirmed (protein LEG1 homolog: HR = 1.24, 95% CI = 1.14 to 1.35; P = 9.79*10−7; ADP–dependent glucokinase: HR = 1.13, 95% CI = 1.03 to 1.23; P = .01).
Conclusion
We identified 2 plasma proteins associated with increased breast cancer risk over the longer term in postmenopausal women; both were confirmed in an independent cohort. If further validated, these plasma protein biomarkers could be considered for utility in current risk stratification tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Chronic Disease Epidemiology, Epidemiology Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
- Cancer Registry Zurich, Zug, Schaffhausen and Schwyz, University Hospital Zurich, Zurich, Switzerland.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
- Department of Oncology, Johns Hopkins University School of Medicine, and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, United States.
- Departments of Population Health and Medicine, New York University Grossman School of Medicine, New York, NY, United States.
- Cancer Epidemiology and Prevention Research Unit, School of Public Health, Imperial College London, London, United Kingdom.
ORCID-Profile: Maria-Eleni Syleouni, Corinne E Joshu, Josef Coresh, Kenneth R Butler, David J Couper, Marcela Guevara, Jiayun Lu, Anna Prizment, Elio Riboli, Meng Ru, Yahya Mahamat Saleh, Mehrnoosh Soori, Kala Visvanathan, Ziqiao Wang, Nilanjan Chatterjee, Sabine Rohrmann, Elizabeth A Platz
Förderung
- HHS
- NHLBI NIH HHS
- NHGRI NIH HHS
- NIH
- NIH HHS
- UZH DocMobility
- NCI NIH HHS
- World Health Organization
Zitieren
APA
Syleouni, M. E., Joshu, C. E., Coresh, J., Gunter, M. J., Butler, K. R., Couper, D. J., Guevara, M., Lu, J., Prizment, A., Riboli, E., Ru, M., Mahamat Saleh, Y., Smith-Byrne, K., Soori, M., Visvanathan, K., Burk, V. A., Wang, Z., Chatterjee, N., Rohrmann, S., & Platz, E. A. (2025). Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf170
Vancouver
Syleouni ME, Joshu CE, Coresh J, Gunter MJ, Butler KR, Couper DJ, et al. Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf170
BibTeX
@article{Syleouni2025,
author = {Syleouni, Maria-Eleni and Joshu, Corinne E and Coresh, Josef and Gunter, Marc J and Butler, Kenneth R and Couper, David J and Guevara, Marcela and Lu, Jiayun and Prizment, Anna and Riboli, Elio and Ru, Meng and Mahamat Saleh, Yahya and Smith-Byrne, Karl and Soori, Mehrnoosh and Visvanathan, Kala and Burk, Vernon A and Wang, Ziqiao and Chatterjee, Nilanjan and Rohrmann, Sabine and Platz, Elizabeth A},
title = {Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf170}
}
EUVIMED